OCS-01 in Treating Inflammation and Pain in Post-cataract Patients
Trial details
- Registry ID
- NCT04130802
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as DexNP
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| OCS-01 in Treating Inflammation and Pain in Post-cataract PatientsNCT04130802 | Oculis | Phase 2 | Completed | 2020-01-31Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |